AVAH
Aveanna Healthcare Holdings, Inc.
Next earnings Aug 5, 2026 (before open) · consensus $0.17 EPS, $648M rev
Last earnings +9.9% on 2026-05-14
$8.66
▲ +2.12%$8.66▲ +77.82%
over 1Y
L $3.74EODHDH $10.27
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.1%
1W+9.3%
1M+18.0%
3M+37.7%
YTD+7.2%
1Y+77.8%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 17 analysts
Buy
Revenue grew 20.2% YoY; but high leverage (liabilities/equity 9.3x).
Revenue (FY2026) $2.43B · FY2026
The read
Middling fundamentals offset by an attractive price (~361% below fair value) — worth a look on the value angle.
Aveanna Healthcare Holdings, Inc. shows $2.43B in FY2026 revenue (+20.2% YoY), a 9.2% net margin, and 115.7% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Revenue | $1.50B | $1.79B | $1.90B | $2.02B | $2.43B |
| Gross profit | $455M | $553M | $595M | $636M | $810M |
| Operating income | -$3.49M | -$642M | $8.07M | $140M | $256M |
| Net income | -$57.0M | -$662M | -$135M | -$10.9M | $225M |
| Diluted EPS | — | -$3.57 | -$0.71 | -$0.06 | $1.05 |
| Net margin | -3.8% | -37.0% | -7.1% | -0.5% | 9.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$2.99B
EV / EBITDA11.2
EV / Sales1.2
EV / FCF27.2
P / FCF17.1
PEG (trailing)0.00
Earnings yield11.9%
FCF yield5.8%
Quality & risk
ROIC (est.)13.6%
Free cash flow$110M
Total debt$1.30B
Net cash-$1.11B
Altman Z-Score1.53 distress
Piotroski F-Score6/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+11.5%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗4Period ending 2026-06-242026-06-26open ↗4Period ending 2026-06-242026-06-26open ↗4Period ending 2026-06-242026-06-26open ↗144Filing2026-06-24open ↗144Filing2026-06-24open ↗144Filing2026-06-24open ↗4Period ending 2026-06-032026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗144Filing2026-06-03open ↗144Filing2026-06-03open ↗144Filing2026-06-03open ↗
Frequently asked
- Is Aveanna Healthcare Holdings, Inc. (AVAH) a buy?
- AVAH currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 20.2% YoY; but high leverage (liabilities/equity 9.3x).
- What is AVAH's fair value?
- A Modified-Graham model based on AVAH's SEC fundamentals estimates a fair value of about $39.90. It is an estimate from reported earnings, not a price target.
- Is AVAH overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, AVAH currently appears undervalued relative to its SEC-grounded earnings power.
- What is Aveanna Healthcare Holdings, Inc.'s quality score?
- AVAH scores 80.68627450980391/100 (grade A-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001832332, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 6:04:44 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.